Risk Management in Biobanks

Sargsyan, Karine; Jaksa, Brigitte; Hartl, Gabriele; Macheiner, Tanja

doi:10.5772/intechopen.91463

Cited by 5 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Using the SWOT analysis as a risk management tool, Sargsyan et al have determined the strengths, weaknesses, opportunities and threats of two emerging Biobanks at the National Institute of Public Health of Kosovo and the University of Tirana Medicine. On the basis of this analysis, they then defined more efficient strategies for biobanking processes and the use of existing infrastructures and knowledge in research [ 19 ]. Miranda et al summarize the potential risks and control measures associated with the acquisition of human samples in research identified in projects under the remit of the UCL/UCLH Biobank for Studying Health and Disease of University College London Cancer Institute at London, as well as transportation, use, storage and disposal of human samples and the security of the premises [ 20 ].…”

Section: Discussionmentioning

confidence: 99%

Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari

Palma

Bolondi²,

Tufaro

et al. 2022

Cancers

View full text Add to dashboard Cite

Although research biobanks are among the most promising tools to fight disease and improve public health, there are a range of risks biobanks may face that mainly need to be assessed in an attempt to be relieved. We conducted a strategic insurance review of an institutional cancer biobank with the aim of both identifying the insurable risks of our own Biobank and gathering useful evidence of primary exposure to insurable risks. In this practical scenario, risks have been outlined and categorized into inherent and residual risks, along with their possible impact on biobank maintenance. Results at the Biobank of the Cancer Institute of Bari showed evidence of potentially significant and intrinsic risk due to highly relevant threats, along with already implemented improvements that significantly reduce risks to a range of relative acceptability.

show abstract

Section: Discussionmentioning

confidence: 99%

Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari

Palma

Bolondi²,

Tufaro

et al. 2022

Cancers

View full text Add to dashboard Cite

show abstract

“…Risk governance is entangled with “design and role, organizational capacity, stakeholder involvement, collaborative decision making and political accountability” as well as responsibility at the institutional level while it necessitates the involvement of various stakeholders “for the development and use of scientific knowledge within the risk governance process” ( Renn and Walker, 2008 ). Risk assessment that includes risk mapping/identification and evaluation is by nature a highly critical component for biobanking organizations ( Sargsyan et al, 2020 ) and should be a regular practice in order to strengthen precautions and create contingency plans that must be in place for unexpected events that will affect biobanking operations ( Eng and Tan, 2019 ).…”

Section: Introductionmentioning

confidence: 99%

Risk mapping for better governance in biobanking: the case of biobank.cy

Akyüz,

Goisauf,

Martin

et al. 2024

Front. Genet.

View full text Add to dashboard Cite

Introduction: Risk governance is central for the successful and ethical operation of biobanks and the continued social license for being custodians of samples and data. Risks in biobanking are often framed as risks for participants, whereas the biobank’s risks are often considered as technical ones. Risk governance relies on identifying, assessing, mitigating and communicating all risks based on technical and standardized procedures. However, within such processes, biobank staff are often involved tangentially. In this study, the aim has been to conduct a risk mapping exercise bringing biobank staff as key actors into the process, making better sense of emerging structure of biobanks.Methods: Based on the qualitative research method of situational analysis as well as the card-based discussion and stakeholder engagement processes, risk mapping was conducted at the biobank setting as an interactive engagement exercise. The analyzed material comprises mainly of moderated group discussions.Results: The findings from the risk mapping activity are framed through an organismic metaphor: the biobank as a growing, living organism in a changing environment, where trust and sustainability are cross-cutting elements in making sense of the risks. Focusing on the situatedness of the dynamics within biobanking activity highlights the importance of prioritizing relations at the core of risk governance and promoting ethicality in the biobanking process by expanding the repertoire of considered risks.Conclusion: With the organismic metaphor, the research brings the diverse group of biobank staff to the central stage for risk governance, highlighting how accounting for such diversity and interdependencies at the biobank setting is a prerequisite for an adaptive risk governance.

show abstract

“…Менеджмент рисков в последние годы стал одним из ключевых аспектов организации и управления работой биобанков и представляет собой часть общей системы управления, направленной на преждевременное выявление, анализ и минимизацию событий, реализация которых способна повлечь за собой негативные последствия для биобанка, а также повлиять на качество биообразцов и ассоциированных с ними данных [1,2].…”

Section: Introductionunclassified

Risk management in biobanking

Borisova¹,

Pokrovskaya²,

Мешков³

et al. 2022

Cardiovasc Ther Prev

View full text Add to dashboard Cite

Risk management is a key aspect of the organization and management of biobanks, which is part of the overall quality management system aimed at early detection, analysis and minimization of events, that can lead to negative consequences for the biobank, as well as affect the quality of biosamples and related data. The article presents the biobanking risk classification with the description of each category.Aim. To develop and implement the methodology for identification, analysis, evaluation and development of risk management measures for the biobanking process in the biobank of the National Medical Research Center for Therapy and Preventive Medicine.Material and methods. We present the methodology of the risk management process developed on the basis of the literary data, world experience and experience of the biobank of the National Medical Research Center for Therapy and Preventive Medicine.Results. The biobanking risk management procedure was developed and implemented in the biobank of the National Medical Research Center for Therapy and Preventive Medicine in 2020. The work carried out made it possible to identify, analyze and evaluate a wide range of potential negative events and actions that could lead to biobank damage, both in the form of financial losses and ethical and technical issues related to the biobanking process. A significant reduction in the frequency of emergency events and the high stability of the biobank operation under the influence of various external factors prove the effectiveness of the approach used.Conclusion. The creation and maintenance of a risk management system in the biobank allows, in combination with other measures, to ensure the safety and high quality of the procedures for collecting, processing and long-term storage of biomaterial and related data by creating an environment that rules out or minimizes the impact of various risks.

show abstract

Risk Management in Biobanks

Cited by 5 publications

References 0 publications

Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari

Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari

Risk mapping for better governance in biobanking: the case of biobank.cy

Risk management in biobanking

Contact Info

Product

Resources

About